In NPC patients, the involvement of EBV infection is usually detected using serological testing to measure elevated IgA antibody responses Viral Capsid Antigen (VCA), Membrane Antigen (MA), and Nuclear Antigens (EBNA) (Middeldorp, 2015). This evidence concerns the gene CD79A and nasopharyngeal carcinoma.